ADIAL PHARMACEUTICALS, INC. Quarterly Debt-to-equity in % from Q3 2021 to Q4 2023

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Adial Pharmaceuticals, Inc. quarterly Debt-to-equity history and growth rate from Q3 2021 to Q4 2023.
Adial Pharmaceuticals, Inc. Debt-to-equity for the quarter ending December 31, 2023 was 36.7 %, a 8.75% decline year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q4 2023	36.7	-3.52	-8.75%	Dec 31, 2023
Q3 2023	57	+11.6	+25.5%	Sep 30, 2023
Q2 2023	57.4	+11.7	+25.5%	Jun 30, 2023
Q1 2023	56.5	+4.25	+8.14%	Mar 31, 2023
Q4 2022	40.2	-23.4	-36.7%	Dec 31, 2022
Q3 2022	45.4	-5.44	-10.7%	Sep 30, 2022
Q2 2022	45.7			Jun 30, 2022
Q1 2022	52.2			Mar 31, 2022
Q4 2021	63.6			Dec 31, 2021
Q3 2021	50.8			Sep 30, 2021

* An asterisk sign (*) next to the value indicates that the value is likely invalid.